The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...

Strategic Partnership to Support Facility Design and Digital Infrastructure Implementation Accelerates Development of State-of-the-Art Advanced Therapy Manufacturing Technologies Enhances Operational ...

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

Made Scientific marked a milestone Aug. 13 as it cut the ribbon on its new cell therapy manufacturing facility and headquarters in Princeton. A number of government officials, industry leaders and ...

Cellares is advancing the global expansion of its state-of-the-art automated cell therapy manufacturing platform. The company announced May 29, in collaboration with Mitsui Fudosan, the establishment ...

On track to meet their long-stated capacity goal for multiple myeloma therapy Carvykti in 2025, Johnson & Johnson and Legend Biotech are already planning the next phase of their cell therapy ...